Literature DB >> 22503731

Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.

Shang-Jyh Kao1, Jen-Liang Su, Chi-Kuan Chen, Ming-Chih Yu, Kuan-Jen Bai, Jer-Hua Chang, Mauo-Ying Bien, Shun-Fa Yang, Ming-Hsien Chien.   

Abstract

The induction of matrix metalloproteinase (MMP)-9 is particularly important for the invasiveness of various cancer cells. Osthole, a natural coumarin derivative extracted from traditional Chinese medicines, is known to inhibit the proliferation of a variety of tumor cells, but the effect of osthole on the invasiveness of tumor cells is largely unknown. This study determines whether and by what mechanism osthole inhibits invasion in CL1-5 human lung adenocarcinoma cells. Herein, we found that osthole effectively inhibited the migratory and invasive abilities of CL1-5 cells. A zymographic assay showed that osthole inhibited the proteolytic activity of MMP-9 in CL1-5 cells. Inhibition of migration, invasion, and MMP2 and/or MMP-9 proteolytic activities was also observed in other lung adenocarcinoma cell lines (H1299 and A549). We further found that osthole inhibited MMP-9 expression at the messenger RNA and protein levels. Moreover, a chromatin immunoprecipitation assay showed that osthole inhibited the transcriptional activity of MMP-9 by suppressing the DNA binding activity of nuclear factor (NF)-κB in the MMP-9 promoter. Using reporter assays with point-mutated promoter constructs further confirmed that the inhibitory effect of osthole requires an NF-κB binding site on the MMP-9 promoter. Western blot and immunofluorescence assays demonstrated that osthole inhibited NF-κB activity by inhibiting IκB-α degradation and NF-κB p65 nuclear translocation. In conclusion, we demonstrated that osthole inhibits NF-κB-mediated MMP-9 expression, resulting in suppression of lung cancer cell invasion and migration, and osthole might be a potential agent for preventing the invasion and metastasis of lung cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503731     DOI: 10.1016/j.taap.2012.03.020

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  30 in total

1.  Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.

Authors:  Haitao Feng; Jin-Jian Lu; Yitao Wang; Lixia Pei; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2017-02-02       Impact factor: 3.405

2.  Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients.

Authors:  Yueh-Hsiang Liao; Chia-Ing Li; Cheng-Chieh Lin; Jaung-Geng Lin; Jen-Huai Chiang; Tsai-Chung Li
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-12       Impact factor: 4.553

3.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITGα3/ITGβ5 signaling.

Authors:  Yue-Qiang Chen; Hai-Yan Song; Zhong-Yan Zhou; Jiao Ma; Zhan-Yang Luo; Ying Zhou; Jian-Yi Wang; Sheng Liu; Xiang-Hui Han
Journal:  Acta Pharmacol Sin       Date:  2021-08-23       Impact factor: 7.169

5.  Promotion of lung tumor growth by interleukin-17.

Authors:  Beibei Xu; James F Guenther; Derek A Pociask; Yu Wang; Jay K Kolls; Zongbing You; Bysani Chandrasekar; Bin Shan; Deborah E Sullivan; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-18       Impact factor: 5.464

6.  Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-κB-mediated upregulation of matrix metalloproteinase-9.

Authors:  Mingjing Zhao; Ying Gao; Lingling Wang; Shuo Liu; Bing Han; Lie Ma; Yuan Ling; Shitao Mao; Xiaoge Wang
Journal:  Int J Med Sci       Date:  2013-06-14       Impact factor: 3.738

7.  S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.

Authors:  Huamin Liu; Lei Wang; Xingang Wang; Zhiwei Cao; Qifeng Yang; Kejun Zhang
Journal:  World J Surg Oncol       Date:  2013-04-23       Impact factor: 2.754

8.  Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro.

Authors:  Xiao-Man Xu; Yi Zhang; Dan Qu; Hong-Bo Liu; Xiu Gu; Guang-Yu Jiao; Li Zhao
Journal:  Exp Ther Med       Date:  2013-01-08       Impact factor: 2.447

9.  Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology.

Authors:  Lixia Pei; Yuanwu Bao; Sheng Liu; Jin Zheng; Xiuping Chen
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.

Authors:  Ruey-Hwang Chou; Shu-Ching Hsieh; Yung-Luen Yu; Min-Hsien Huang; Yi-Chang Huang; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.